We could imagine that PHLDA3 plays a role as a tumor suppressor in a broad range of cancers having wild-type p53, and this p53-PHLDA3 tumor-suppressive pathway could be a novel target for cancer therapy. The gene discussed is TP53; the disease is cancer.